肝硬化食管胃底静脉曲张破裂出血的综合治疗
|
摘要
食道胃底静脉曲张破裂出血是肝硬化的严重致死性并发症之一。门脉压力增高与食道胃底曲张静脉破损是其发生的必备条件及主要风险因素,其临床治疗方法涉及药物、内镜、介入、手术及肝移植,优势各异。笔者从门静脉压力、曲张静脉破损及肝功能损害等风险因素控制的角度,分析评估了目前其各种临床治疗方法的临床效果及作用机制。控制单一风险因素的治疗方法的临床效果往往有限,而对多种风险因素进行联合控制的综合治疗方案具有较好的临床疗效。内镜结合脾动脉主干栓塞的联合治疗方案具备优于其它治疗方案的理论优势。
Esophogastric variceal bleeding is one of the severe and lethal complications of liver cirrhosis, and portal hypertension and esophogastric variceal vein damage are essential and main risk factors for its occurrence. Its clinical treatment includes medications, endoscopic or interventional therapy, surgery and liver transplantation, each with specific advantages. From the perspectives of control of the risk factors such as portal vein pressure, varicose vein damage and liver function injury, the authors analyzed and evaluated the clinical effect and mechanism of various clinical treatment methods. The clinical effect of single risk factor control is often limited, while the combined treatment for multiple control of the risk factors has better clinical efficacy. Furthermore, endoscopy combined with splenic arterial trunk embolization has theoretical advantages over other treatment options.
Esophogastric variceal bleeding is one of the severe and lethal complications of liver cirrhosis, and portal hypertension and esophogastric variceal vein damage are essential and main risk factors for its occurrence. Its clinical treatment includes medications, endoscopic or interventional therapy, surgery and liver transplantation, each with specific advantages. From the perspectives of control of the risk factors such as portal vein pressure, varicose vein damage and liver function injury, the authors analyzed and evaluated the clinical effect and mechanism of various clinical treatment methods. The clinical effect of single risk factor control is often limited, while the combined treatment for multiple control of the risk factors has better clinical efficacy. Furthermore, endoscopy combined with splenic arterial trunk embolization has theoretical advantages over other treatment options.
引文
[1]张静,陈明锴.门脉高压症的诊断与治疗进展[J].胃肠病学和肝病学杂志,2018,27(3):341-345.doi:10.3969/j.issn.1006-5709.2018.03.023.Zhang J,Chen MK.Progress of diagnosis and treatment of portal hypertension[J].Chinese Journal of Gastroenterology and Hepatology,2018,27(3):341-345.d o i:10.3969/j.issn.1006-5709.2018.03.023.
[2]Toubia N,Sanyal AJ.Portal Hypertension and Variceal Hemorrhage[J].Med Clin N Am,2008,92(3):551-574.
[3]Cremers I,Ribeiro S.Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis[J].Therap Adv Gastroenterol,2014,7(5):206-216.doi:10.1177/1756283X14538688.
[4]Garcia-Tsao G,Sanyal AJ,Grace ND,et al.Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis[J].Am J Gastroenterol,2007,102(9):2086-2102.doi:10.1111/j.1572-0241.2007.01481.x.
[5]贺加星,阴继凯,刘凡,等.肝硬化门静脉高压并发上消化道出血的相关危险因素分析[J].中国普通外科杂志,2015,24(1):127-130.doi:10.3978/j.issn.1005-6947.2015.01.024.He JX,Yin JK,Liu F,et al.Analysis of risk factors associated with liver cirrhosis and portal hypertension complicated with upper gastrointestinal bleeding[J].Chinese Journal of General Surgery,2015,24(1):127-130.doi:10.3978/j.issn.1005-6947.2015.01.024.
[6]Garcia-Tsao G,Bosch J.Management of varices and variceal hemorrhage in cirrhosis[J].N Engl J Med,2010,362(9):823-832.doi:10.1056/NEJMra0901512.
[7]M?ller S,Bendtsen F.The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis[J].Liver Int,2018,38(4):570-580.doi:10.1111/liv.13589.
[8]Bolognesi M,Di Pascoli M,Verardo A,et al.Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis[J].World J Gastroenterol,2014,20(10):2555-2563.doi:10.3748/wjg.v20.i10.2555.
[9]Sauerbruch T,Mengel M,Dollinger M,et al.Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy[J].Gastroenterology,2015,149(3):660-668.doi:10.1053/j.gastro.2015.05.011.
[10]Sinagra E,Perricone G,D'Amico M,et al.Systematic review with meta analysis:the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis[J].Aliment Pharmacol Ther,2014,39(6):557-568.doi:10.1111/apt.12634.
[11]Groszmann RJ,Garcia-Tsao G,Bosch J,et al.Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis[J].N Engl J Med,2005,353(21):2254-2261.doi:10.1056/NEJMoa044456.
[12]Baiges A,Hernández-Gea V,Bosch J.Pharmacologic prevention of variceal bleeding and rebleeding[J].Hepatol Int,2018,12(Suppl1):68-80.doi:10.1007/s12072-017-9833-y.
[13]Ding Q,Tian XG,Li Y,et al.Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERKsignaling pathway[J].World J Gastroenterol,2015,21(32):9566-9576.doi:10.3748/wjg.v21.i32.9566.
[14]Seo YS.Prevention and management of gastroesophageal varices[J].Clin Mol Hepatol,2018,24(1):20-42.doi:10.3350/cmh.2017.0064.
[15]Qi XS,Bao YX,Bai M,et al.Nonselective beta-blockers in cirrhotic patients with no or small varices:A meta-analysis[J].World J Gastroenterol,2015,21(10):3100-3108.doi:10.3748/wjg.v21.i10.3100.
[16]邓晗,祁兴顺.《2015年英国肝硬化静脉曲张出血防治指南》摘译[J].临床肝胆病杂志,2015,31(6):852-854.doi:10.3969/j.issn.1001-5256.2015.06.007.Deng H,Qi XS.UK guidelines on the management of variceal haemorrhage in cirrhotic patients(2015):an excerpt of recommendations[J].Journal of Clinical Hepatology,2015,31(6):852-854.doi:10.3969/j.issn.1001-5256.2015.06.007.
[17]Kurt M.Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites[J].Hepatology,2011,53(4):1411-1412.doi:10.1002/hep.24051.
[18]Wells M,Chande N,Adams P,et al.Meta-analysis:vasoactive medications for the management of acute variceal bleeds[J].Aliment Pharmacol Ther,2012,35(11):1267-1278.doi:10.1111/j.1365-2036.2012.05088.x.
[19]Escorsell A,Ruiz del Arbol L,Planas R,et al.Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding:the TEST study[J].Hepatology,2000,32(3):471-476.doi:10.1053/jhep.2000.16601.
[20]Seo YS,Park SY,Kim MY,et al.Lack of difference among terlipressin,somatostatin,and octreotide in the control of acute gastroesophageal variceal hemorrhage[J].Hepatology,2014,60(3):954-963.doi:10.1002/hep.27006.
[21]Haider S,Hussain Q,Tabassum S,et al.Doppler waveform study as indicator of change of portal pressure after administration of octreotide[J].Pak J Med Sci,2016,32(4):935-938.doi:10.12669/pjms.324.10275.
[22]Baik SK,Jeong PH,Sang WJ,et al.Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis:a randomized comparison[J].Am J Gastroenterol,2005,100(3):631-635.doi:10.1111/j.1572-0241.2005.41381.x.
[23]Benoit JN,Barrowman JA,Harper SL,et al.Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension[J].Am J Physiol,1984,247(5 Pt 1):G486-493.doi:10.1152/ajpgi.1984.247.5.G486.
[24]Pinzani M,Milani S,De Franco R,et al.Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells[J].Gastroenterology,1996,110(2):534-548.
[25]杨文燕,吴建新,戴强,等.长效奥曲肽对大鼠肝纤维化门静脉高压形成的影响[J].世界华人消化杂志,2008,16(25):2815-2819.doi:10.3969/j.issn.1009-3079.2008.25.005.Yang WY,Wu JX,Dai Q,et al.Effect of long-acting octreotide on portal hypertension in rats with liver fibrosis[J].World Chinese Journal of Digestology,2008,16(25):2815-2819.doi:10.3969/j.is sn.1009-3079.2008.25.005.
[26]Cirera I,Feu F,Luca A,et al.Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis:a double-blind hemodynamic investigation[J].Hepatology,2010,22(1):106-111.
[27]Bellis L,Berzigotti A,Abraldes JG,et al.Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis[J].Hepatology,2003,37(2):378-384.doi:10.1053/jhep.2003.50053.
[28]肖华鑫,王敏,李健,等.普萘洛尔联合5-单硝酸异山梨酯对肝硬化门静脉高压血流动力学参数的影响[J].中国病原生物学杂志,2012,7(3):220-221.Xiao HX,Wang M,Li J,et al.The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on hemodynamics parameters in patients with cirrhosis and portal hypertension[J].Journal of Pathogen Biology,2012,7(3):220-221.
[29]Gluud LL,Langholz E,Krag A.Meta-analysis:isosorbidemononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices[J].Aliment Pharmacol Ther,2010,32(7):859-871.
[30]石青,郭武华.介入治疗肝硬化门脉高压症并发食管胃底静脉曲张破裂出血研究进展[J].实用肝脏病杂志,2016,19(5):519-523.doi:10.3969/j.issn.1672-5069.2016.05.003.Shi Q,Guo WH.Interventional treatment of variceal bleeding in cirrhotic patients[J].Journal of Practical Hepatology,2016,19(5):519-523.doi:10.3969/j.issn.1672-5069.2016.05.003.
[31]Boyer TD.Transjugular intrahepatic portosystemic shunt:current status[J].Gastroenterology,2003,124(6):1700-1710.
[32]R?ssle M,Haag K,Ochs A,et al.The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding[J].N Engl JMed,1994,330(3):165-171.doi:10.1056/NEJM199401203300303.
[33]Barton RE,Rosch J,Saxon RR,et al.TIPS:short and long term results:a survey of 1750 patients[J].Semin Interv Radiol,1995,12(4):364-367.
[34]Haskal Z,Martin L,Cardella J,et al.Quality improvement guidelines for transjugular intrahepatic portosystemic shunts[J].JVasc Interv Radiol,2003,14(9 Pt 2):S265-270.
[35]Halabi SA,Sawas T,Sadat B,et al.Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients:a meta-analysis of randomized controlled trials[J].J Gastroenterol Hepatol,2016,31(9):1519-1526.doi:10.1111/jgh.13303.
[36]Garcíapagán JC,Bosch J.ACP Journal Club.Early use of TIPSin patients with cirrhosis and variceal bleeding[J].Ann Intern Med,2010,153(10):JC5-13.doi:10.7326/0003-4819-153-10-201011160-02013.
[37]Bureau C,Thabut D,Oberti F,et al.Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase TransplantFree Survival of Patients With Cirrhosis and Recurrent Ascites[J].Gastroenterology,2017,152(1):157-163.doi:10.1053/j.gastro.2016.09.016.
[38]贺克武,张国兵.TIPS治疗门静脉高压[J].肝胆外科杂志,2017,25(5):328-331.doi:10.3969/j.issn.1006-4761.2017.05.004.He KW,Zhang GB.TIPS for portal hypertension[J].Journal of Hepatobiliary Surgery,2017,25(5):328-331.doi:10.3969/j.issn.1006-4761.2017.05.004.
[39]Rosemurgy AS,Zervos EE,Goode SE,et al.Differential effects on portal and effective hepatic blood flow.A comparison between transjugular intrahepatic portasystemic shunt and small-diameter H-graft portacaval shunt[J].Ann Surg,1997,225(5):601-607.
[40]Loffroy R,Estivalet L,Cherblanc V,et al.Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage[J].World J Gastroenterol,2013,19(37):6131-6143.doi:10.3748/wjg.v19.i37.6131.
[41]Laberge JM,Ferrell LD,Ring EJ,et al.Histopathologic study of transjugular intrahepatic portosystemic shunts[J].J Vasc Interv Radiol,1991,2(4):549-556.
[42]何长生,吴性江.TIPS治疗食管胃底静脉曲张破裂出血长期疗效的影响因素[J].中华肝脏外科手术学电子杂志,2018,7(2):103-106.doi:10.3877/cma.j.issn.2095-3232.2018.02.005.He CS,Wu XJ.Influential factors for long-term efficacy of IPSin treatment of esophageal variceal bleeding[J].Chinese Journal of Hepatic Surgery,2018,7(2):103-106.doi:10.3877/cma.j.issn.2095-3232.2018.02.005.
[43]Bureau C,Garcia Pagan JC,Layrargues GP,et al.Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts:long-term results of a randomized multicentre study[J].Liver Int,2007,27(6):742-747.doi:10.1111/j.1478-3231.2007.01522.x.
[44]Fidelman N,Kwan SW,LaBerge JM,et al.The transjugular intrahepatic portosystemic shunt:an update[J].AJR Am JRoentgenol,2012,199(4):746-755.doi:10.2214/AJR.12.9101.
[45]Zheng M,Chen Y,Bai J,et al.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients:metaanalysis update[J].J Clin Gastroenterol,2008,42(5):507-516.doi:10.1097/MCG.0b013e31815576e6.
[46]Unger LW,Stork T,Bucsics T,et al.The role of TIPS in the management of liver transplant candidates[J].United European Gastroenterol J,2017,5(8):1100-1107.doi:10.1177/2050640617704807.
[47]Wang YB,Zhang JY,Zhang F,et al.Partial Splenic Artery Embolization to Treat Hypersplenism Secondary to Hepatic Cirrhosis:A Meta-Analysis[J].Am Surg,2017,83(3):274-283.
[48]Kato M,Shimohashi N,Ouchi J,et al.Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism[J].J Gastroenterol,2005,40(11):1076-1077.doi:10.1007/s00535-005-1693-x.
[49]Taniai N,Onda M,Tajiri T,et al.Endoscopic variceal ligation(EVL)combined with partial splenic embolization(PSE)[J].Hepatogastroenterology,1999,46(29):2849-2853.
[50]Ohmoto K,Yamamoto S.Prevention of variceal recurrence,bleeding,and death in cirrhosis patients with hypersplenism,especially those with severe thrombocytopenia[J].Hepatogastroenterology,2003,50(54):1766-1769.
[51]Murata K,Shiraki K,Takase K,et al.Long term follow-up for patients with liver cirrhosis after partial splenic embolization[J].Hepatogastroenterology,1996,43(11):1212-1217.
[52]Piffaretti G,Tozzi M,Lomazzi C,et al.Splenic artery aneurysms:postembolization syndrome and surgical complications[J].Am JSurg,2007,193(2):166-170.doi:10.1016/j.amjsurg.2006.09.007.
[53]Xu RY,Liu B,Lin N.Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension[J].World J Gastroenterol,2004,10(7):1072-1074.
[54]Sakai T,Shiraki K,Inoue H,et al.Complications of partial splenic embolization in cirrhotic patients[J].Dig Dis Sci,2002,47(2):388-391.
[55]Heyman SN,Rosen S,Rosenberger C.Renal parenchymal hypoxia,hypoxia adaptation,and the pathogenesis of radiocontrast nephropathy[J].Clin J Am Soc Nephrol,2008,3(1):288-296.doi:10.2215/CJN.02600607.
[56]Yoshida H,Mamada Y,Taniai N,et al.Partial splenic embolization[J].Hepatol Res,2008,38(3):225-233.doi:10.1111/j.1872-034X.2007.00302.x.
[57]Kayacetin E,Efe D,Do?an C.Portal and splenic hemodynamics in cirrhotic patients:relationship between esophageal variceal bleeding and the severity of hepatic failure[J].J Gastroenterol,2004,39(7):661-667.doi:10.1007/s00535-003-1362-x.
[58]Aoki H,Hasumi A,Hashizume M,et al.Hemodynamic analysis of findings in patients with portal hypertension:multicenter analysis in Japan.Japan Portal Hypertension Study Group[J].Hepatogastroenterology,1995,42(6):1030-1038.
[59]Eipel C,Abshagen K,Ritter J,et al.Splenectomy improves survival by increasing arterial blood supply in a rat model of reduced size liver[J].Transpl Int,2010,23(10):998-1007.doi:10.1111/j.1432-2277.2010.01079.x.
[60]Wang W,Tam MD,Spain J,et al.Gelfoam-assisted Amplatzer vascular plug technique for rapid occlusion in proximal splenic artery embolization[J].AJR Am J Roentgenol,2013,200(3):677-681.doi:10.2214/AJR.12.8949.
[61]Irie T.New embolization microcoil consisting of firm and flexible segments:preliminary clinical experience[J].Cardiovasc Intervent Radiol,2006,29(6):986-990.doi:10.1007/s00270-005-0364-x.
[62]王承恩,孙成建,王彦华,等.可解脱球囊治疗门静脉高压和脾功能亢进的疗效观察[J].中华肝脏病杂志,2015,23(6):433-436.doi:10.3760/cma.j.issn.1007-3418.2015.06.008.Wang CE,Sun CJ,Wang YH,et al.Efficacy of splenic artery trunk embolization with detachable balloon for portal hypertension and hypersplenism[J].Chinese Journal of Hepatology,2015,23(6):433-436.doi:10.3760/cma.j.issn.1007-3418.2015.06.008.
[63]He XH,Gu JJ,Li WT,et al.Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism[J].World J Gastroenterol,2012,18(24):3138-3144.doi:10.3748/wjg.v18.i24.3138.
[64]He XH,Li WT,Peng WJ,et al.Total embolization of the main splenic artery as a supplemental treatment modality for hypersplenism[J].World J Gastroenterol,2011,17(24):2953-2957.doi:10.3748/wjg.v17.i24.2953.
[65]Madoff DC,Denys A,Wallace MJ,et al.Splenic arterial interventions:anatomy,indications,technical considerations,and potential complications[J].Radiographics,2005,25(Suppl 1):S191-211.doi:10.1148/rg.25si055504.
[66]Li YN,Miao XY,Hai ZQ,et al.Splenic artery trunk embolization reduces the surgical risk of liver transplantation[J].Hepatobiliary Pancreat Dis Int,2015,14(3):263-268.
[67]王林安.脾动脉主干栓塞对肝硬化的疗效观察[J].甘肃科技,2003,19(2):58.doi:10.3969/j.issn.1000-0952.2003.02.030.Wang LA.Efficacy observation of splenic arterial trunk embolization for liver cirrhosis[J].Gansu Science and Technology,2003,19(2):58.doi:10.3969/j.issn.1000-0952.2003.02.030.
[68]Zong G Q,Fei Y,Liu R M.Comparison of effects of devascularization versus shunt on patients with portal hypertension:a meta-analysis[J].Chirurgia(Bucur),2015,110(1):15-25.
[69]李宏为,杨卫平,陈皓,等.部分门体静脉分流术在门静脉高压症外科治疗中的合理应用[J].外科理论与实践,2012,17(6):601-603.doi:10.3969/j.issn.1007-9610.2012.06.001.Li HW,Yang WP,Chen H.Rational use of partial transjugular intrahepatic portosystemic shunt in surgical treatment of portal hypertension[J].Journal of Surgery Concepts&Practice,2012,17(6):601-603.doi:10.3969/j.issn.1007-9610.2012.06.001.
[70]Mercado MA.Surgical treatment for portal hypertension[J].Br JSurg,2015,102(7):717-718.doi:10.1002/bjs.9849.
[71]周松,杨爱国.门奇联合断流术对门脉高压血液动力学的影响[J].肝胆外科杂志,2003,11(2):108-109.doi:10.3969/j.issn.1006-4761.2003.02.012.Zhou S,Yang AG.Effects of esophagogastric devascularization combined with splenectomy and esophageal transection on portal and systemic hemodynamics[J].Journal of Hepatobiliary Surgery,2003,11(2):108-109.doi:10.3969/j.issn.1006-4761.2003.02.012.
[72]Zheng X,Liu Q,Yao Y.et al.Laparoscopic splenectomy and esophagogastric devascularization is a safe,effective,minimally invasive alternative for the treatment of portal hypertension with refractory variceal bleeding[J].Surg Innov,2013,20(1):32-39.doi:10.1177/1553350612441863.
[73]许斌,刘妮,许建华.手助腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门脉高压症[J].中国普通外科杂志,2015,24(1):145-148.doi:10.3978/j.issn.1005-6947.2015.01.030.Xu B,Liu N,Xu JH.Hand-assisted laparoscopic splenectomy combined with pericardial devascularization for hepatic cirrhosis with portal hypertension[J].Chinese Journal of General Surgery,2015,24(1):145-148.doi:10.3978/j.issn.1005-6947.2015.01.030.
[74]贺莎莎,范晓棠,石绣江,等.肝硬化门静脉高压症脾切除术后发生门静脉血栓的风险因素及其预测模型的建立[J].中国普通外科杂志,2016,25(12):1766-1772.doi:10.3978/j.issn.1005-6947.2016.12.016.He SS,Fan XT,Shi XJ,et al.Risk factors for portal vein thrombosis after splenectomy for portal hypertension due to liver cirrhosis and establishment of its prediction model[J].Chinese Journal of General Surgery,2016,25(12):1766-1772.doi:10.3978/j.issn.1005-6947.2016.12.016.
[75]乔自勇,高晓明,闫军波,等.脾动脉及胃冠状静脉主干结扎在肝硬化门静脉高压症上消化道出血中的应用[J].白求恩医学杂志,2014,12(4):326-328.doi:10.3969/j.issn.1672-2876.2014.04.010.Qiao ZY,Gao XM,Yan JB,et al.Ligation of splenic artery and gastric coronary vein trunk in treatment of emergent epatocirrhosis portal hypertention with upper gastrointestinal bleeding[J].Journal of Bethune Military Medical College,2014,12(4):326-328.doi:10.3969/j.issn.1672-2876.2014.04.010.
[76]Zilberstein B,Sallet JA,Ramos A,et al.Video laparoscopy for the treatment of bleeding esophageal varices[J].Surg Laparosc Endosc,1997,7(3):185-191.
[77]Helmy A,Salama IA,Schwaitzberg SD.Laparoscopic esophagogastric devascularization in bleeding varices[J].Surg Endosc,2003,17(10):1614-1619.doi:10.1007/s00464-002-8928-1.
[78]Voros D,Polydorou A,Polymeneas G,et al.Long-term results with the modified Sugiura procedure for the management of variceal bleeding:standing the test of time in the treatment of bleeding esophageal varices[J].World J Surg,2012,36(3):659-666.doi:10.1007/s00268-011-1418-7.
[79]Bari K,Garcia-Tsao G.Treatment of portal hypertension[J].World J Gastroenterol,2012,18(11):1166-1175.doi:10.3748/wjg.v18.i11.1166.
[80]程慧桢,王凤霞,崔海彬,等.肝硬化门静脉高压食管胃静脉曲张出血的防治[J].中国临床医生,2013,41(8):7-8.doi:10.3969/j.issn.1008-1089.2013.08.004.Cheng HZ,Wang FX,Cui HB,et al.Prophylaxis and treatment of esophagogastric variceal bleeding caused by portal hypertension due to liver cirrhosis[J].Chinese Journal for Clinicians,2013,41(8):7-8.doi:10.3969/j.issn.1008-1089.2013.08.004.
[81]Kezer CA,Gupta N.The Role of Therapeutic Endoscopy in Patients With Cirrhosis-Related Causes of Gastrointestinal Bleeding[J].Curr Gastroenterol Rep,2018,20(7):31.doi:10.1007/s11894-018-0637-6.
[82]de Franchis R.Evolving consensus in portal hypertension.Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].J Hepatol,2005,43(1):167-176.doi:10.1016/j.jhep.2005.05.009.
[83]孙自勤.食管胃静脉曲张破裂出血的内镜治疗[J].现代消化及介入诊疗,2013,18(1):27-29.doi:10.3961/j.issn.1672-2159.2013.01.009.Sun ZQ.Endoscopic treatment of esophagogastric variceal bleeding[J].Modern Digestion&Intervention,2013,18(1):27-29.doi:10.3961/j.issn.1672-2159.2013.01.009.
[84]董辉,陈武,陈贺,等.肝硬化门脉高压食管胃底静脉曲张出血内镜下止血治疗新进展[J].中国实用医药,2011,6(19):82-83.doi:10.3969/j.issn.1673-7555.2011.19.053.Dong H,Chen W,Chen H,et al.Progress of endoscopic hemostasis for esophagogastric variceal bleeding caused by portal hypertension secondary to liver cirrhosis[J].China Practical Medical,2011,6(19):82-83.doi:10.3969/j.issn.1673-7555.2011.19.053.
[85]Berzigotti A.Advances and challenges in cirrhosis and portal hypertension[J].BMC Med,2017,15(1):200.doi:10.1186/s12916-017-0966-6.
[86]Henderson JM.Surgical treatment of portal hypertension[J].Baillieres Best Pract Res Clin Gastroenterol,2000,14(6):911-925.doi:10.1053/bega.2000.0138.
[87]Puente A,Hernández-Gea V,Graupera I,et al.Drugs plus ligation to prevent rebleeding in cirrhosis:an updated systematic review[J].Liver Int,2014,34(6):823-833.doi:10.1111/liv.12452.
[88]Monescillo A,Martínez-Lagares F,Ruiz-del-Arbol L,et al.Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding[J].Hepatology,2004,40(4):793-801.doi:10.1002/hep.20386.
[89]García-Pagán JC,Caca K,Bureau C,et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].N Engl J Med,2010,362(25):2370-2379.doi:10.1056/NEJMoa0910102.
[90]Rudler M,Cluzel P,Corvec TL,et al.Early TIPSS placement prevents rebleeding in high risk patients with variceal bleeding,without improving survival[J].Aliment Pharmacol Ther,2014,40(9):1074-1080.doi:10.1111/apt.12934.
[91]Ripamonti R,Ferral H,Alonzo M,et al.Transjugular intrahepatic portosystemic shunt-related complications and practical solutions[J].Semin Intervent Radiol,2006,23(2):165-176.
[92]Riggio O,Angeloni S,Salvatori FM,et al.Incidence,natural history,and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylenecovered stent grafts[J].Am J Gastroenterol,2008,103(11):2738-2746.doi:10.1111/j.1572-0241.2008.02102.x.
[93]Riggio O,Nardelli S,Moscucci F,et al.Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J].Clin Liver Dis,2012,16(1):133-146.doi:10.1016/j.cld.2011.12.008.
[94]Reiberger T,Püsp?k A,Schoder M,et al.Austrian consensus guidelines on the management and treatment of portal hypertension(Billroth III)[J].Wien Klin Wochenschr,2017,129(Suppl 3):135-158.doi:10.1007/s00508-017-1262-3.
[95]Buechter M,Kahraman A,Manka P,et al.Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPSimplantation[J].PLoS One,2017,12(5):e0177401.doi:10.1371/journal.pone.0177401.
[96]Hadduck TA,McWilliams JP.Partial splenic artery embolization in cirrhotic patients[J].World J Radiol,2014,6(5):160-168.doi:10.4329/wjr.v6.i5.160.
[97]Pang X,Li T,Wang C.Splenic artery embolization with detachable balloons for hypersplenism[J].J Int Med Res,2018,46(10):4111-4119.doi:10.1177/0300060518786419.
[98]Colaneri RP,Coelho FF,de Cleva R,et al.Laparoscopic Treatment of Presinusoidal Schistosomal Portal Hypertension Associated With Postoperative Endoscopic Treatment:Results of a New Approach[J].Surg Laparosc Endosc Percutan Tech,2017,27(2):90-93.doi:10.1097/SLE.0000000000000302.
[2]Toubia N,Sanyal AJ.Portal Hypertension and Variceal Hemorrhage[J].Med Clin N Am,2008,92(3):551-574.
[3]Cremers I,Ribeiro S.Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis[J].Therap Adv Gastroenterol,2014,7(5):206-216.doi:10.1177/1756283X14538688.
[4]Garcia-Tsao G,Sanyal AJ,Grace ND,et al.Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis[J].Am J Gastroenterol,2007,102(9):2086-2102.doi:10.1111/j.1572-0241.2007.01481.x.
[5]贺加星,阴继凯,刘凡,等.肝硬化门静脉高压并发上消化道出血的相关危险因素分析[J].中国普通外科杂志,2015,24(1):127-130.doi:10.3978/j.issn.1005-6947.2015.01.024.He JX,Yin JK,Liu F,et al.Analysis of risk factors associated with liver cirrhosis and portal hypertension complicated with upper gastrointestinal bleeding[J].Chinese Journal of General Surgery,2015,24(1):127-130.doi:10.3978/j.issn.1005-6947.2015.01.024.
[6]Garcia-Tsao G,Bosch J.Management of varices and variceal hemorrhage in cirrhosis[J].N Engl J Med,2010,362(9):823-832.doi:10.1056/NEJMra0901512.
[7]M?ller S,Bendtsen F.The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis[J].Liver Int,2018,38(4):570-580.doi:10.1111/liv.13589.
[8]Bolognesi M,Di Pascoli M,Verardo A,et al.Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis[J].World J Gastroenterol,2014,20(10):2555-2563.doi:10.3748/wjg.v20.i10.2555.
[9]Sauerbruch T,Mengel M,Dollinger M,et al.Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy[J].Gastroenterology,2015,149(3):660-668.doi:10.1053/j.gastro.2015.05.011.
[10]Sinagra E,Perricone G,D'Amico M,et al.Systematic review with meta analysis:the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis[J].Aliment Pharmacol Ther,2014,39(6):557-568.doi:10.1111/apt.12634.
[11]Groszmann RJ,Garcia-Tsao G,Bosch J,et al.Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis[J].N Engl J Med,2005,353(21):2254-2261.doi:10.1056/NEJMoa044456.
[12]Baiges A,Hernández-Gea V,Bosch J.Pharmacologic prevention of variceal bleeding and rebleeding[J].Hepatol Int,2018,12(Suppl1):68-80.doi:10.1007/s12072-017-9833-y.
[13]Ding Q,Tian XG,Li Y,et al.Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERKsignaling pathway[J].World J Gastroenterol,2015,21(32):9566-9576.doi:10.3748/wjg.v21.i32.9566.
[14]Seo YS.Prevention and management of gastroesophageal varices[J].Clin Mol Hepatol,2018,24(1):20-42.doi:10.3350/cmh.2017.0064.
[15]Qi XS,Bao YX,Bai M,et al.Nonselective beta-blockers in cirrhotic patients with no or small varices:A meta-analysis[J].World J Gastroenterol,2015,21(10):3100-3108.doi:10.3748/wjg.v21.i10.3100.
[16]邓晗,祁兴顺.《2015年英国肝硬化静脉曲张出血防治指南》摘译[J].临床肝胆病杂志,2015,31(6):852-854.doi:10.3969/j.issn.1001-5256.2015.06.007.Deng H,Qi XS.UK guidelines on the management of variceal haemorrhage in cirrhotic patients(2015):an excerpt of recommendations[J].Journal of Clinical Hepatology,2015,31(6):852-854.doi:10.3969/j.issn.1001-5256.2015.06.007.
[17]Kurt M.Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites[J].Hepatology,2011,53(4):1411-1412.doi:10.1002/hep.24051.
[18]Wells M,Chande N,Adams P,et al.Meta-analysis:vasoactive medications for the management of acute variceal bleeds[J].Aliment Pharmacol Ther,2012,35(11):1267-1278.doi:10.1111/j.1365-2036.2012.05088.x.
[19]Escorsell A,Ruiz del Arbol L,Planas R,et al.Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding:the TEST study[J].Hepatology,2000,32(3):471-476.doi:10.1053/jhep.2000.16601.
[20]Seo YS,Park SY,Kim MY,et al.Lack of difference among terlipressin,somatostatin,and octreotide in the control of acute gastroesophageal variceal hemorrhage[J].Hepatology,2014,60(3):954-963.doi:10.1002/hep.27006.
[21]Haider S,Hussain Q,Tabassum S,et al.Doppler waveform study as indicator of change of portal pressure after administration of octreotide[J].Pak J Med Sci,2016,32(4):935-938.doi:10.12669/pjms.324.10275.
[22]Baik SK,Jeong PH,Sang WJ,et al.Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis:a randomized comparison[J].Am J Gastroenterol,2005,100(3):631-635.doi:10.1111/j.1572-0241.2005.41381.x.
[23]Benoit JN,Barrowman JA,Harper SL,et al.Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension[J].Am J Physiol,1984,247(5 Pt 1):G486-493.doi:10.1152/ajpgi.1984.247.5.G486.
[24]Pinzani M,Milani S,De Franco R,et al.Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells[J].Gastroenterology,1996,110(2):534-548.
[25]杨文燕,吴建新,戴强,等.长效奥曲肽对大鼠肝纤维化门静脉高压形成的影响[J].世界华人消化杂志,2008,16(25):2815-2819.doi:10.3969/j.issn.1009-3079.2008.25.005.Yang WY,Wu JX,Dai Q,et al.Effect of long-acting octreotide on portal hypertension in rats with liver fibrosis[J].World Chinese Journal of Digestology,2008,16(25):2815-2819.doi:10.3969/j.is sn.1009-3079.2008.25.005.
[26]Cirera I,Feu F,Luca A,et al.Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis:a double-blind hemodynamic investigation[J].Hepatology,2010,22(1):106-111.
[27]Bellis L,Berzigotti A,Abraldes JG,et al.Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis[J].Hepatology,2003,37(2):378-384.doi:10.1053/jhep.2003.50053.
[28]肖华鑫,王敏,李健,等.普萘洛尔联合5-单硝酸异山梨酯对肝硬化门静脉高压血流动力学参数的影响[J].中国病原生物学杂志,2012,7(3):220-221.Xiao HX,Wang M,Li J,et al.The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on hemodynamics parameters in patients with cirrhosis and portal hypertension[J].Journal of Pathogen Biology,2012,7(3):220-221.
[29]Gluud LL,Langholz E,Krag A.Meta-analysis:isosorbidemononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices[J].Aliment Pharmacol Ther,2010,32(7):859-871.
[30]石青,郭武华.介入治疗肝硬化门脉高压症并发食管胃底静脉曲张破裂出血研究进展[J].实用肝脏病杂志,2016,19(5):519-523.doi:10.3969/j.issn.1672-5069.2016.05.003.Shi Q,Guo WH.Interventional treatment of variceal bleeding in cirrhotic patients[J].Journal of Practical Hepatology,2016,19(5):519-523.doi:10.3969/j.issn.1672-5069.2016.05.003.
[31]Boyer TD.Transjugular intrahepatic portosystemic shunt:current status[J].Gastroenterology,2003,124(6):1700-1710.
[32]R?ssle M,Haag K,Ochs A,et al.The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding[J].N Engl JMed,1994,330(3):165-171.doi:10.1056/NEJM199401203300303.
[33]Barton RE,Rosch J,Saxon RR,et al.TIPS:short and long term results:a survey of 1750 patients[J].Semin Interv Radiol,1995,12(4):364-367.
[34]Haskal Z,Martin L,Cardella J,et al.Quality improvement guidelines for transjugular intrahepatic portosystemic shunts[J].JVasc Interv Radiol,2003,14(9 Pt 2):S265-270.
[35]Halabi SA,Sawas T,Sadat B,et al.Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients:a meta-analysis of randomized controlled trials[J].J Gastroenterol Hepatol,2016,31(9):1519-1526.doi:10.1111/jgh.13303.
[36]Garcíapagán JC,Bosch J.ACP Journal Club.Early use of TIPSin patients with cirrhosis and variceal bleeding[J].Ann Intern Med,2010,153(10):JC5-13.doi:10.7326/0003-4819-153-10-201011160-02013.
[37]Bureau C,Thabut D,Oberti F,et al.Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase TransplantFree Survival of Patients With Cirrhosis and Recurrent Ascites[J].Gastroenterology,2017,152(1):157-163.doi:10.1053/j.gastro.2016.09.016.
[38]贺克武,张国兵.TIPS治疗门静脉高压[J].肝胆外科杂志,2017,25(5):328-331.doi:10.3969/j.issn.1006-4761.2017.05.004.He KW,Zhang GB.TIPS for portal hypertension[J].Journal of Hepatobiliary Surgery,2017,25(5):328-331.doi:10.3969/j.issn.1006-4761.2017.05.004.
[39]Rosemurgy AS,Zervos EE,Goode SE,et al.Differential effects on portal and effective hepatic blood flow.A comparison between transjugular intrahepatic portasystemic shunt and small-diameter H-graft portacaval shunt[J].Ann Surg,1997,225(5):601-607.
[40]Loffroy R,Estivalet L,Cherblanc V,et al.Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage[J].World J Gastroenterol,2013,19(37):6131-6143.doi:10.3748/wjg.v19.i37.6131.
[41]Laberge JM,Ferrell LD,Ring EJ,et al.Histopathologic study of transjugular intrahepatic portosystemic shunts[J].J Vasc Interv Radiol,1991,2(4):549-556.
[42]何长生,吴性江.TIPS治疗食管胃底静脉曲张破裂出血长期疗效的影响因素[J].中华肝脏外科手术学电子杂志,2018,7(2):103-106.doi:10.3877/cma.j.issn.2095-3232.2018.02.005.He CS,Wu XJ.Influential factors for long-term efficacy of IPSin treatment of esophageal variceal bleeding[J].Chinese Journal of Hepatic Surgery,2018,7(2):103-106.doi:10.3877/cma.j.issn.2095-3232.2018.02.005.
[43]Bureau C,Garcia Pagan JC,Layrargues GP,et al.Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts:long-term results of a randomized multicentre study[J].Liver Int,2007,27(6):742-747.doi:10.1111/j.1478-3231.2007.01522.x.
[44]Fidelman N,Kwan SW,LaBerge JM,et al.The transjugular intrahepatic portosystemic shunt:an update[J].AJR Am JRoentgenol,2012,199(4):746-755.doi:10.2214/AJR.12.9101.
[45]Zheng M,Chen Y,Bai J,et al.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients:metaanalysis update[J].J Clin Gastroenterol,2008,42(5):507-516.doi:10.1097/MCG.0b013e31815576e6.
[46]Unger LW,Stork T,Bucsics T,et al.The role of TIPS in the management of liver transplant candidates[J].United European Gastroenterol J,2017,5(8):1100-1107.doi:10.1177/2050640617704807.
[47]Wang YB,Zhang JY,Zhang F,et al.Partial Splenic Artery Embolization to Treat Hypersplenism Secondary to Hepatic Cirrhosis:A Meta-Analysis[J].Am Surg,2017,83(3):274-283.
[48]Kato M,Shimohashi N,Ouchi J,et al.Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism[J].J Gastroenterol,2005,40(11):1076-1077.doi:10.1007/s00535-005-1693-x.
[49]Taniai N,Onda M,Tajiri T,et al.Endoscopic variceal ligation(EVL)combined with partial splenic embolization(PSE)[J].Hepatogastroenterology,1999,46(29):2849-2853.
[50]Ohmoto K,Yamamoto S.Prevention of variceal recurrence,bleeding,and death in cirrhosis patients with hypersplenism,especially those with severe thrombocytopenia[J].Hepatogastroenterology,2003,50(54):1766-1769.
[51]Murata K,Shiraki K,Takase K,et al.Long term follow-up for patients with liver cirrhosis after partial splenic embolization[J].Hepatogastroenterology,1996,43(11):1212-1217.
[52]Piffaretti G,Tozzi M,Lomazzi C,et al.Splenic artery aneurysms:postembolization syndrome and surgical complications[J].Am JSurg,2007,193(2):166-170.doi:10.1016/j.amjsurg.2006.09.007.
[53]Xu RY,Liu B,Lin N.Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension[J].World J Gastroenterol,2004,10(7):1072-1074.
[54]Sakai T,Shiraki K,Inoue H,et al.Complications of partial splenic embolization in cirrhotic patients[J].Dig Dis Sci,2002,47(2):388-391.
[55]Heyman SN,Rosen S,Rosenberger C.Renal parenchymal hypoxia,hypoxia adaptation,and the pathogenesis of radiocontrast nephropathy[J].Clin J Am Soc Nephrol,2008,3(1):288-296.doi:10.2215/CJN.02600607.
[56]Yoshida H,Mamada Y,Taniai N,et al.Partial splenic embolization[J].Hepatol Res,2008,38(3):225-233.doi:10.1111/j.1872-034X.2007.00302.x.
[57]Kayacetin E,Efe D,Do?an C.Portal and splenic hemodynamics in cirrhotic patients:relationship between esophageal variceal bleeding and the severity of hepatic failure[J].J Gastroenterol,2004,39(7):661-667.doi:10.1007/s00535-003-1362-x.
[58]Aoki H,Hasumi A,Hashizume M,et al.Hemodynamic analysis of findings in patients with portal hypertension:multicenter analysis in Japan.Japan Portal Hypertension Study Group[J].Hepatogastroenterology,1995,42(6):1030-1038.
[59]Eipel C,Abshagen K,Ritter J,et al.Splenectomy improves survival by increasing arterial blood supply in a rat model of reduced size liver[J].Transpl Int,2010,23(10):998-1007.doi:10.1111/j.1432-2277.2010.01079.x.
[60]Wang W,Tam MD,Spain J,et al.Gelfoam-assisted Amplatzer vascular plug technique for rapid occlusion in proximal splenic artery embolization[J].AJR Am J Roentgenol,2013,200(3):677-681.doi:10.2214/AJR.12.8949.
[61]Irie T.New embolization microcoil consisting of firm and flexible segments:preliminary clinical experience[J].Cardiovasc Intervent Radiol,2006,29(6):986-990.doi:10.1007/s00270-005-0364-x.
[62]王承恩,孙成建,王彦华,等.可解脱球囊治疗门静脉高压和脾功能亢进的疗效观察[J].中华肝脏病杂志,2015,23(6):433-436.doi:10.3760/cma.j.issn.1007-3418.2015.06.008.Wang CE,Sun CJ,Wang YH,et al.Efficacy of splenic artery trunk embolization with detachable balloon for portal hypertension and hypersplenism[J].Chinese Journal of Hepatology,2015,23(6):433-436.doi:10.3760/cma.j.issn.1007-3418.2015.06.008.
[63]He XH,Gu JJ,Li WT,et al.Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism[J].World J Gastroenterol,2012,18(24):3138-3144.doi:10.3748/wjg.v18.i24.3138.
[64]He XH,Li WT,Peng WJ,et al.Total embolization of the main splenic artery as a supplemental treatment modality for hypersplenism[J].World J Gastroenterol,2011,17(24):2953-2957.doi:10.3748/wjg.v17.i24.2953.
[65]Madoff DC,Denys A,Wallace MJ,et al.Splenic arterial interventions:anatomy,indications,technical considerations,and potential complications[J].Radiographics,2005,25(Suppl 1):S191-211.doi:10.1148/rg.25si055504.
[66]Li YN,Miao XY,Hai ZQ,et al.Splenic artery trunk embolization reduces the surgical risk of liver transplantation[J].Hepatobiliary Pancreat Dis Int,2015,14(3):263-268.
[67]王林安.脾动脉主干栓塞对肝硬化的疗效观察[J].甘肃科技,2003,19(2):58.doi:10.3969/j.issn.1000-0952.2003.02.030.Wang LA.Efficacy observation of splenic arterial trunk embolization for liver cirrhosis[J].Gansu Science and Technology,2003,19(2):58.doi:10.3969/j.issn.1000-0952.2003.02.030.
[68]Zong G Q,Fei Y,Liu R M.Comparison of effects of devascularization versus shunt on patients with portal hypertension:a meta-analysis[J].Chirurgia(Bucur),2015,110(1):15-25.
[69]李宏为,杨卫平,陈皓,等.部分门体静脉分流术在门静脉高压症外科治疗中的合理应用[J].外科理论与实践,2012,17(6):601-603.doi:10.3969/j.issn.1007-9610.2012.06.001.Li HW,Yang WP,Chen H.Rational use of partial transjugular intrahepatic portosystemic shunt in surgical treatment of portal hypertension[J].Journal of Surgery Concepts&Practice,2012,17(6):601-603.doi:10.3969/j.issn.1007-9610.2012.06.001.
[70]Mercado MA.Surgical treatment for portal hypertension[J].Br JSurg,2015,102(7):717-718.doi:10.1002/bjs.9849.
[71]周松,杨爱国.门奇联合断流术对门脉高压血液动力学的影响[J].肝胆外科杂志,2003,11(2):108-109.doi:10.3969/j.issn.1006-4761.2003.02.012.Zhou S,Yang AG.Effects of esophagogastric devascularization combined with splenectomy and esophageal transection on portal and systemic hemodynamics[J].Journal of Hepatobiliary Surgery,2003,11(2):108-109.doi:10.3969/j.issn.1006-4761.2003.02.012.
[72]Zheng X,Liu Q,Yao Y.et al.Laparoscopic splenectomy and esophagogastric devascularization is a safe,effective,minimally invasive alternative for the treatment of portal hypertension with refractory variceal bleeding[J].Surg Innov,2013,20(1):32-39.doi:10.1177/1553350612441863.
[73]许斌,刘妮,许建华.手助腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门脉高压症[J].中国普通外科杂志,2015,24(1):145-148.doi:10.3978/j.issn.1005-6947.2015.01.030.Xu B,Liu N,Xu JH.Hand-assisted laparoscopic splenectomy combined with pericardial devascularization for hepatic cirrhosis with portal hypertension[J].Chinese Journal of General Surgery,2015,24(1):145-148.doi:10.3978/j.issn.1005-6947.2015.01.030.
[74]贺莎莎,范晓棠,石绣江,等.肝硬化门静脉高压症脾切除术后发生门静脉血栓的风险因素及其预测模型的建立[J].中国普通外科杂志,2016,25(12):1766-1772.doi:10.3978/j.issn.1005-6947.2016.12.016.He SS,Fan XT,Shi XJ,et al.Risk factors for portal vein thrombosis after splenectomy for portal hypertension due to liver cirrhosis and establishment of its prediction model[J].Chinese Journal of General Surgery,2016,25(12):1766-1772.doi:10.3978/j.issn.1005-6947.2016.12.016.
[75]乔自勇,高晓明,闫军波,等.脾动脉及胃冠状静脉主干结扎在肝硬化门静脉高压症上消化道出血中的应用[J].白求恩医学杂志,2014,12(4):326-328.doi:10.3969/j.issn.1672-2876.2014.04.010.Qiao ZY,Gao XM,Yan JB,et al.Ligation of splenic artery and gastric coronary vein trunk in treatment of emergent epatocirrhosis portal hypertention with upper gastrointestinal bleeding[J].Journal of Bethune Military Medical College,2014,12(4):326-328.doi:10.3969/j.issn.1672-2876.2014.04.010.
[76]Zilberstein B,Sallet JA,Ramos A,et al.Video laparoscopy for the treatment of bleeding esophageal varices[J].Surg Laparosc Endosc,1997,7(3):185-191.
[77]Helmy A,Salama IA,Schwaitzberg SD.Laparoscopic esophagogastric devascularization in bleeding varices[J].Surg Endosc,2003,17(10):1614-1619.doi:10.1007/s00464-002-8928-1.
[78]Voros D,Polydorou A,Polymeneas G,et al.Long-term results with the modified Sugiura procedure for the management of variceal bleeding:standing the test of time in the treatment of bleeding esophageal varices[J].World J Surg,2012,36(3):659-666.doi:10.1007/s00268-011-1418-7.
[79]Bari K,Garcia-Tsao G.Treatment of portal hypertension[J].World J Gastroenterol,2012,18(11):1166-1175.doi:10.3748/wjg.v18.i11.1166.
[80]程慧桢,王凤霞,崔海彬,等.肝硬化门静脉高压食管胃静脉曲张出血的防治[J].中国临床医生,2013,41(8):7-8.doi:10.3969/j.issn.1008-1089.2013.08.004.Cheng HZ,Wang FX,Cui HB,et al.Prophylaxis and treatment of esophagogastric variceal bleeding caused by portal hypertension due to liver cirrhosis[J].Chinese Journal for Clinicians,2013,41(8):7-8.doi:10.3969/j.issn.1008-1089.2013.08.004.
[81]Kezer CA,Gupta N.The Role of Therapeutic Endoscopy in Patients With Cirrhosis-Related Causes of Gastrointestinal Bleeding[J].Curr Gastroenterol Rep,2018,20(7):31.doi:10.1007/s11894-018-0637-6.
[82]de Franchis R.Evolving consensus in portal hypertension.Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].J Hepatol,2005,43(1):167-176.doi:10.1016/j.jhep.2005.05.009.
[83]孙自勤.食管胃静脉曲张破裂出血的内镜治疗[J].现代消化及介入诊疗,2013,18(1):27-29.doi:10.3961/j.issn.1672-2159.2013.01.009.Sun ZQ.Endoscopic treatment of esophagogastric variceal bleeding[J].Modern Digestion&Intervention,2013,18(1):27-29.doi:10.3961/j.issn.1672-2159.2013.01.009.
[84]董辉,陈武,陈贺,等.肝硬化门脉高压食管胃底静脉曲张出血内镜下止血治疗新进展[J].中国实用医药,2011,6(19):82-83.doi:10.3969/j.issn.1673-7555.2011.19.053.Dong H,Chen W,Chen H,et al.Progress of endoscopic hemostasis for esophagogastric variceal bleeding caused by portal hypertension secondary to liver cirrhosis[J].China Practical Medical,2011,6(19):82-83.doi:10.3969/j.issn.1673-7555.2011.19.053.
[85]Berzigotti A.Advances and challenges in cirrhosis and portal hypertension[J].BMC Med,2017,15(1):200.doi:10.1186/s12916-017-0966-6.
[86]Henderson JM.Surgical treatment of portal hypertension[J].Baillieres Best Pract Res Clin Gastroenterol,2000,14(6):911-925.doi:10.1053/bega.2000.0138.
[87]Puente A,Hernández-Gea V,Graupera I,et al.Drugs plus ligation to prevent rebleeding in cirrhosis:an updated systematic review[J].Liver Int,2014,34(6):823-833.doi:10.1111/liv.12452.
[88]Monescillo A,Martínez-Lagares F,Ruiz-del-Arbol L,et al.Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding[J].Hepatology,2004,40(4):793-801.doi:10.1002/hep.20386.
[89]García-Pagán JC,Caca K,Bureau C,et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].N Engl J Med,2010,362(25):2370-2379.doi:10.1056/NEJMoa0910102.
[90]Rudler M,Cluzel P,Corvec TL,et al.Early TIPSS placement prevents rebleeding in high risk patients with variceal bleeding,without improving survival[J].Aliment Pharmacol Ther,2014,40(9):1074-1080.doi:10.1111/apt.12934.
[91]Ripamonti R,Ferral H,Alonzo M,et al.Transjugular intrahepatic portosystemic shunt-related complications and practical solutions[J].Semin Intervent Radiol,2006,23(2):165-176.
[92]Riggio O,Angeloni S,Salvatori FM,et al.Incidence,natural history,and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylenecovered stent grafts[J].Am J Gastroenterol,2008,103(11):2738-2746.doi:10.1111/j.1572-0241.2008.02102.x.
[93]Riggio O,Nardelli S,Moscucci F,et al.Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J].Clin Liver Dis,2012,16(1):133-146.doi:10.1016/j.cld.2011.12.008.
[94]Reiberger T,Püsp?k A,Schoder M,et al.Austrian consensus guidelines on the management and treatment of portal hypertension(Billroth III)[J].Wien Klin Wochenschr,2017,129(Suppl 3):135-158.doi:10.1007/s00508-017-1262-3.
[95]Buechter M,Kahraman A,Manka P,et al.Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPSimplantation[J].PLoS One,2017,12(5):e0177401.doi:10.1371/journal.pone.0177401.
[96]Hadduck TA,McWilliams JP.Partial splenic artery embolization in cirrhotic patients[J].World J Radiol,2014,6(5):160-168.doi:10.4329/wjr.v6.i5.160.
[97]Pang X,Li T,Wang C.Splenic artery embolization with detachable balloons for hypersplenism[J].J Int Med Res,2018,46(10):4111-4119.doi:10.1177/0300060518786419.
[98]Colaneri RP,Coelho FF,de Cleva R,et al.Laparoscopic Treatment of Presinusoidal Schistosomal Portal Hypertension Associated With Postoperative Endoscopic Treatment:Results of a New Approach[J].Surg Laparosc Endosc Percutan Tech,2017,27(2):90-93.doi:10.1097/SLE.0000000000000302.